When innovation struggles to reach the market
Healthcare innovation creates value when evidence becomes relevant to real decisions, adoption becomes repeatable, and scale delivers meaningful outcomes.
AZZART Advisory explores the strategic choices that connect these stages across healthcare and life sciences.
The AZZART Acceleration Framework
Innovation → Adoption → Scale → Strategic Value
Progress depends on crossing three thresholds: evidence and relevance; repeatability and capability; outcomes and economics.
Three thresholds for progress
Each transition asks a different strategic question: what makes an innovation relevant, what makes adoption repeatable, and what makes scale valuable?
About
Catherine Azzariti is a senior leader in molecular diagnostics and healthcare innovation with more than 20 years of international experience across strategy, commercialization and portfolio development.
She has led strategic initiatives across Europe and global markets, helping healthcare companies accelerate the adoption and commercialization of innovative diagnostic technologies.
Through AZZART Advisory, she partners with diagnostics, medtech and digital health companies to accelerate market impact and unlock growth opportunities.
AREAS OF EXPERTISE
• Molecular diagnostics
• Medtech commercialization
• Digital health strategy
• Market adoption pathways
• Go-to-market strategy
• Portfolio growth strategy
• Strategic transformation
